Mirum Pharmaceuticals, Inc. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Absorption, Distribution, Metabolism, and Excretion of…Absorption, Distribution, Metabolism, and Excretion of [14C]-MRM-3379

   Trial completed

   Also in this update: Final enrollment: 7 participants (planned 8)

   Mirum Pharmaceuticals, Inc.·Phase 1· NCT07712718· Registry history of NCT07712718 on ClinicalTrials.gov (opens the registry)

   Updated Oct 7, 2026

2. Minor

   Brelovitug (BJT-778) vs Bulevirtide · Chronic Hepatitis Delta…Brelovitug (BJT-778) vs Bulevirtide · Chronic Hepatitis Delta Infection (AZURE-2)

   Trial sites expanded: 53 → 57 locations

   Mirum Pharmaceuticals, Inc.·Phase 3· NCT07200908· Registry history of NCT07200908 on ClinicalTrials.gov (opens the registry)

   Updated Oct 8, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.